ReviewThe world journal of men's health2020
An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy.
Review in The world journal of men's health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Reintervention rates after minimally invasive benign prostatic hyperplasia therapies: a systematic review including industry involvement.World journal of urology · 2025Pooled it
- Comparative Trends in the Treatment of Male Lower Urinary Tract Symptoms in South Korea and the United States of America (USA) Based on Korean National Health Insurance Data.The world journal of men's health · 2026Article
- Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation-a narrative review from EAU endourology.World journal of urology · 2026Review
- Research progress on ejaculatory function preservation in minimally invasive surgical treatments for benign prostatic hyperplasia: a narrative review.Translational andrology and urology · 2025Review
- Urethral SparingThe world journal of men's health · 2025Article
- Construction of a nomogram to predict urethral stricture after transurethral resection of the prostate: A retrospective cohort study.PloS one · 2025Article
- Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia.Current urology reports · 2024Review
- Does dutasteride reduce the bleeding in transurethral resection of the prostate in patients on antiplatelet drugs?Current urology · 2024Article
- A critical evaluation of OptilumeTranslational andrology and urology · 2024Article
- Omentin-1 inhibits the development of benign prostatic hyperplasia by attenuating local inflammation.Molecular medicine (Cambridge, Mass.) · 2024Article
- Epidemiological characteristics of 214,063 hospital admissions to adult urological departments in Poland in 2022.Central European journal of urology · 2024Article
- Exploring the causal relationship: bidirectional mendelian randomization study on benign prostatic hyperplasia and cardiovascular diseases.Frontiers in genetics · 2024Article
- Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasia.World journal of urology · 2023Article
- Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures.Prostate international · 2023Review
- Surgical Complications in the Management of Benign Prostatic Hyperplasia Treatment.Current urology reports · 2022Review
- Comprehensive Review on Current Controversies and Debate in Prostate Artery Embolization.Turkish journal of urology · 2022Article
- An overview of benign prostatic hyperplasia and its appreciation in Greco-Arab (Unani) system of medicine.Asian journal of urology · 2022Review
- Analysis of Risk Factors and Nursing Strategies for Postoperative Hemorrhage of Benign Prostatic Hyperplasia.Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Indications, techniques, and role of new minimally invasive benign prostate hyperplasia surgical options.Turkish journal of urology · 2020Review
- A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.European urology open science · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Benign prostatic hyperplasia (BPH), a common cause of lower urinary tract symptoms in the elderly male population, has conventionally treated by transurethral resection of the prostate (TURP). During recent years, newer minimally invasive therapies (MITs) have entered the playing field and challenged TURP with their convenience, lack of sexual side effects, and overall safety. The present paper provides an update on the more heavily studied and most recent MITs, analyzing their mechanism of action, tolerability, and efficacy in clinical practice. Particularly, robust clinical data have propelled UroLift and Rezuum to the forefront in the armamentarium of minimally invasive BPH treatment. Newer mechanical therapies such as the temporary implantable nitinol device, ClearRing, ZenFlow Spring, and Butterfly are appealing options as they forego cutting, ablation, heating, or removing prostatic tissue. It is obvious that there is wide variation in the degree of clinical readiness of each modality and only time and long-term, multicenter studies will decide which of these therapies are accepted by the patient and urologist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.